Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 30 Issue 6
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2012  >  30(6): 447-448

WU Ning-ning. Therapeutic effect and adverse reaction of Thalidomide combined with dexamethasone in elderly patients with multiple myeloma[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 447-448. doi: 10.3969/j.issn.1006-0111.2012.06.014
Citation: WU Ning-ning. Therapeutic effect and adverse reaction of Thalidomide combined with dexamethasone in elderly patients with multiple myeloma[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 447-448. doi: 10.3969/j.issn.1006-0111.2012.06.014
shu

Therapeutic effect and adverse reaction of Thalidomide combined with dexamethasone in elderly patients with multiple myeloma

doi: 10.3969/j.issn.1006-0111.2012.06.014

  • Department of Hematology, Second Hospital of Ningbo, Ningbo 315000, China

  • Received Date: 2012-02-21
  • Rev Recd Date: 2012-05-28
  • Objective To observe the efficiency and safety of thalidomide combined with dexamethasone in elderly patients with multiple myeloma. Methods A total of 50 elderly patients with multiple myeloma in initial treatment were administered thalidomide combined with dexamethasone. Thalidomide was administered at an initial dose of 50 mg once-daily orally followed by gradually increased in 50 mg according to patients' tolerance to a maximum of 200 mg once-daily orally, dexamethasone was administered at 20 mg once-daily IV in 1~4 d, 9~12 d and 17~20 d with 28 d as a course of treatment. The efficiency after 4 courses of treatment eva-luate was evauated. Results Complete remission were in 15 cases, immense partial remission in 12 cases, partial remission in 13 cases, no change in 5 cases and progression of disease in 5 cases. The total effective rate was 80%. During treatment, there were 17 patients suffering from hypersomnia, 16 onstipation, 16 lassitude, 10 increased blood sugar, 8 peripheral neuropathy and 3 rashes. All the patients could tolerant after expectant treatment. Conclusion It could be an effective method of thalidomide combined with dexamethasone in elderly patients with multiple myeloma.
  • [1] 沙信山,李永辉,张桂芳,等.小剂量沙利度胺联合长春地辛、吡喃阿霉素和地塞米松方案治疗老年多发性骨髓瘤[J].中华实用诊断与治疗杂志,2009,23(3):303.
    [2] 中国多发性骨髓瘤工作组.中国多发性骨髓瘤诊治指南[J].中华内科杂志,2008,47(10):869.
    [3] Facon T, Mary JY, Pegourie B, et al. Dexamethasone-based regi-mens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy[J]. Blood,2006,107(4):1292.
    [4] Fujita J,Mestre JR,Zeldis JB,et al.Thalidomide and its analogues inhibit lipop1ysaccharide mediated linduction of cyclooxygenase 2[J].Clin Cancer Res,2001,7(11):3349.
    [5] 顾惠慈.三氧化二砷联合化疗治疗难治复发多发骨髓瘤的临床疗效分析[J].实用诊断与治疗杂志,2006,20(12):918.
    [6] 张之南.血液病诊断及疗效标准[M].第2版,北京:科学出版社,1998:73.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(7143) PDF downloads(2484) Cited by()

Related
Proportional views

Therapeutic effect and adverse reaction of Thalidomide combined with dexamethasone in elderly patients with multiple myeloma

doi: 10.3969/j.issn.1006-0111.2012.06.014
  • Department of Hematology, Second Hospital of Ningbo, Ningbo 315000, China
  • Received Date: 2012-02-21
  • Rev Recd Date: 2012-05-28

Abstract: Objective To observe the efficiency and safety of thalidomide combined with dexamethasone in elderly patients with multiple myeloma. Methods A total of 50 elderly patients with multiple myeloma in initial treatment were administered thalidomide combined with dexamethasone. Thalidomide was administered at an initial dose of 50 mg once-daily orally followed by gradually increased in 50 mg according to patients' tolerance to a maximum of 200 mg once-daily orally, dexamethasone was administered at 20 mg once-daily IV in 1~4 d, 9~12 d and 17~20 d with 28 d as a course of treatment. The efficiency after 4 courses of treatment eva-luate was evauated. Results Complete remission were in 15 cases, immense partial remission in 12 cases, partial remission in 13 cases, no change in 5 cases and progression of disease in 5 cases. The total effective rate was 80%. During treatment, there were 17 patients suffering from hypersomnia, 16 onstipation, 16 lassitude, 10 increased blood sugar, 8 peripheral neuropathy and 3 rashes. All the patients could tolerant after expectant treatment. Conclusion It could be an effective method of thalidomide combined with dexamethasone in elderly patients with multiple myeloma.

WU Ning-ning. Therapeutic effect and adverse reaction of Thalidomide combined with dexamethasone in elderly patients with multiple myeloma[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 447-448. doi: 10.3969/j.issn.1006-0111.2012.06.014
Citation: WU Ning-ning. Therapeutic effect and adverse reaction of Thalidomide combined with dexamethasone in elderly patients with multiple myeloma[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 447-448. doi: 10.3969/j.issn.1006-0111.2012.06.014
shu

    HTML

Reference (6)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return